| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 652738 | 04276034 | ABILIFY 1 MG/ML SOLUCION ORAL | ABILIFY 1 MG/ML SOLUCION ORAL, 1 frasco de 150 ml | 1 mg/ml | 6 | 150 | 26 | 1 frasco de 150 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/04276034/04276034_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/04276034/04276034_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29813 | 8454 | 2005-12-16 | 1 | 1 | 1 | 2005-12-16 | 2005-12-16 | 1 | 2011-10-17 | View Edit Delete | ||||||||||||
| 656738 | 50880 | FOSFOCINA 250 MG/5 ML POLVO PARA SUSPENSION ORAL | FOSFOCINA 250 MG/5 ML POLVO PARA SUSPENSION ORAL, 1 frasco de 120 ml | 250 mg/5 ml | 6 | 120 | 26 | 1 frasco de 120 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/50880/50880_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/50880/50880_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 945 | 945 | 1972-12-01 | 1 | 1 | 1 | 1972-12-01 | 2007-12-17 | 1 | 2011-09-09 | 759670 | View Edit Delete | |||||||||||
| 663870 | 07416002 | ECALTA 100 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | ECALTA 100 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial | 100 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07416002/07416002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07416002/07416002_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29446 | 11622 | 2009-10-27 | 1 | 1 | 1 | 2009-10-27 | 2009-10-27 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 700554 | 50355 | TRILOMBRIN COMPRIMIDOS | TRILOMBRIN COMPRIMIDOS, 6 comprimidos | 250 mg | 5 | 6 | 10 | 6 comprimidos | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5478 | 5478 | 1972-07-01 | 1 | 1 | 1 | 1972-07-01 | 2015-05-18 | 1 | 2012-01-02 | 839779, 759035, 999879 | View Edit Delete | |||||||||||
| 700755 | 78258 | ULTRA-LEVURA 250 MG POLVO PARA SUSPENSION ORAL | ULTRA-LEVURA 250 MG POLVO PARA SUSPENSION ORAL , 20 sobres | 250 mg | 35 | 20 | 64 | 20 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78258/78258_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78258/78258_p.pdf | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68155 | 29563 | 2013-12-05 | 1 | 1 | 1 | 2013-12-05 | 2013-12-05 | 1 | 2014-04-23 | View Edit Delete | ||||||||||||
| 704070 | 79116 | BRONCHOSTOP ANTITUSIVO Y EXPECTORANTE SOLUCION ORAL | BRONCHOSTOP ANTITUSIVO Y EXPECTORANTE SOLUCION ORAL , 1 frasco de 200 ml | 120 mg/15 ml + 830 mg/15 ml | 6 | 200 | 26 | 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79116/79116_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79116/79116_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 14258 | 88108 | 2014-10-20 | 1 | 1 | 1 | 2014-10-20 | 2014-10-30 | 1 | 2015-10-06 | View Edit Delete | ||||||||||||
| 709218 | 80482 | ARIPIPRAZOL NORMON 1 MG/ML SOLUCION ORAL EFG | ARIPIPRAZOL NORMON 1 MG/ML SOLUCION ORAL EFG , 150 ml | 1 mg/ml | 6 | 150 | 26 | 150 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/80482/80482_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/80482/80482_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2015-12-15 | 1 | 1 | 1 | 2015-12-15 | 2015-12-15 | 1 | 2016-05-19 | View Edit Delete | ||||||||||||
| 709769 | 80580 | ABIK 1 MG/ML SOLUCION ORAL EFG | ABIK 1 MG/ML SOLUCION ORAL EFG , 150 ml | 1 mg/ml | 6 | 150 | 26 | 150 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/80580/80580_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/80580/80580_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2016-01-25 | 1 | 1 | 1 | 2016-01-25 | 2016-01-25 | 1 | 2016-03-08 | View Edit Delete | ||||||||||||
| 724275 | 83666 | ANIDULAFUNGINA ACCORD 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | ANIDULAFUNGINA ACCORD 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial | 100 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83666/83666_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83666/83666_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | 11104 | 2018-12-12 | 1 | 1 | 1 | 2018-12-13 | 2018-12-12 | 1 | 2019-07-31 | View Edit Delete | ||||||||||||
| 724867 | 83850 | ARIPIPRAZOL AUROVITAS 1 MG/ML SOLUCION ORAL EFG | ARIPIPRAZOL AUROVITAS 1 MG/ML SOLUCION ORAL EFG 1 frasco de 150 ml | 1 mg/ml | 6 | 150 | 26 | 1 frasco de 150 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83850/83850_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83850/83850_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | 16109 | 2019-02-20 | 1 | 1 | 1 | 2019-02-21 | 2019-02-20 | 1 | 2020-02-11 | View Edit Delete | ||||||||||||
| 725243 | 83990 | ANIDULAFUNGINA NORMON 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | ANIDULAFUNGINA NORMON 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG 1 vial | 100 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83990/83990_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83990/83990_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2019-04-02 | 1 | 1 | 1 | 2019-04-03 | 2019-04-02 | 1 | 2019-05-13 | View Edit Delete | ||||||||||||
| 725443 | 2123-13-1-2010 | ULTRA-LEVURA 250 MG POLVO PARA SUSPENSION ORAL | ULTRA-LEVURA 250 MG POLVO PARA SUSPENSION ORAL, 10 sobres | 250 mg | 35 | 10 | 64 | 10 sobres | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20462 | 17193 | 2019-04-24 | 1 | 1 | 1 | 2019-04-25 | 2019-04-24 | 1 | 2020-06-23 | View Edit Delete | ||||||||||||
| 725574 | 2123-13-1-2010 | ULTRA-LEVURA 250 MG POLVO PARA SUSPENSION ORAL | ULTRA-LEVURA 250 MG POLVO PARA SUSPENSION ORAL, 20 sobres | 250 mg | 35 | 20 | 64 | 20 sobres | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20462 | 17193 | 2019-04-24 | 1 | 1 | 1 | 2019-04-25 | 2019-04-25 | 1 | 2023-10-26 | View Edit Delete | ||||||||||||
| 728873 | 85225 | ANIDULAFUNGINA REIG JOFRE 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | ANIDULAFUNGINA REIG JOFRE 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial (30 ml) | 100 mg | 45 | 1 | 34 | 1 vial (30 ml) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85225/85225_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85225/85225_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 2367 | 2367 | 2020-07-02 | 1 | 1 | 1 | 2020-07-03 | 2020-07-02 | 1 | 2023-06-28 | View Edit Delete | ||||||||||||
| 730799 | 85912 | FESOTERODINA NORMON 8 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | FESOTERODINA NORMON 8 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG, 28 comprimidos | 8 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85912/85912_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85912/85912_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2021-04-14 | 1 | 1 | 1 | 2021-04-15 | 2021-04-15 | 1 | 2022-04-03 | View Edit Delete | ||||||||||||
| 730800 | 85913 | FESOTERODINA NORMON 4 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | FESOTERODINA NORMON 4 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG, 28 comprimidos | 4 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85913/85913_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85913/85913_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2021-04-14 | 1 | 1 | 1 | 2021-04-15 | 2021-04-15 | 1 | 2022-04-03 | View Edit Delete | ||||||||||||
| 735115 | 86878 | ULTRA-LEVURA 250 MG POLVO Y DISOLVENTE PARA SUSPENSION ORAL | ULTRA-LEVURA 250 MG POLVO Y DISOLVENTE PARA SUSPENSION ORAL, 10 frascos | 250 mg | 6 | 10 | 17 | 10 frascos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86878/86878_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86878/86878_p.pdf | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68155 | 29563 | 2022-04-19 | 1 | 1 | 1 | 2022-04-20 | 2022-04-19 | 1 | 2025-07-10 | View Edit Delete | ||||||||||||
| 756685 | 87877 | FESOTERODINA ALTER 4 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | FESOTERODINA ALTER 4 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG, 28 comprimidos | 4 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/87877/87877_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/87877/87877_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | 137 | 2022-06-20 | 1 | 1 | 1 | 2022-06-21 | 2022-06-20 | 1 | 2022-10-10 | View Edit Delete | ||||||||||||
| 756686 | 87878 | FESOTERODINA ALTER 8 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | FESOTERODINA ALTER 8 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG, 28 comprimidos | 8 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/87878/87878_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/87878/87878_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | 137 | 2022-06-20 | 1 | 1 | 1 | 2022-06-21 | 2022-06-20 | 1 | 2022-10-10 | View Edit Delete | ||||||||||||
| 757987 | 87956 | FESOTERODINA AUROVITAS 8 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | FESOTERODINA AUROVITAS 8 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG , 28 comprimidos | 8 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/87956/87956_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/87956/87956_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | 16109 | 2022-07-06 | 1 | 1 | 1 | 2022-07-07 | 2022-07-06 | 1 | 2022-08-11 | View Edit Delete | ||||||||||||
| 757988 | 87957 | FESOTERODINA AUROVITAS 4 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | FESOTERODINA AUROVITAS 4 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG , 28 comprimidos | 4 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/87957/87957_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/87957/87957_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | 16109 | 2022-07-06 | 1 | 1 | 1 | 2022-07-07 | 2022-07-06 | 1 | 2022-08-11 | View Edit Delete | ||||||||||||
| 761857 | 88570 | EMYLIF 50 MG PELICULA BUCODISPERSABLE | EMYLIF 50 MG PELICULA BUCODISPERSABLE, 56 sobres | 50 mg | 35 | 56 | 10 | 56 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88570/88570_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88570/88570_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 16687 | 29563 | 2023-04-04 | 1 | 1 | 1 | 2023-04-04 | 2023-04-04 | 1 | 2023-06-15 | View Edit Delete | ||||||||||||
| 769610 | 24076IP3 | OXITRIL 30 MG COMPRIMIDOS GASTRORRESISTENTES | OXITRIL 30 MG COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 30 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/24076IP3/24076IP3_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29270 | 23628 | 2026-01-09 | 1 | 1 | 1 | 2026-01-10 | 2026-01-09 | 1 | 2026-02-13 | View Edit Delete | ||||||||||||
| 769611 | 24077IP3 | OXITRIL 60 MG COMPRIMIDOS GASTRORRESISTENTES | OXITRIL 60 MG COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 60 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/24077IP3/24077IP3_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29270 | 23628 | 2026-01-09 | 1 | 1 | 1 | 2026-01-10 | 2026-01-09 | 1 | 2026-02-13 | View Edit Delete | ||||||||||||
| 769613 | 24077IP3 | OXITRIL 60 MG COMPRIMIDOS GASTRORRESISTENTES | OXITRIL 60 MG COMPRIMIDOS GASTRORRESISTENTES, 56 comprimidos | 60 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/24077IP3/24077IP3_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29270 | 23628 | 2026-01-09 | 1 | 1 | 1 | 2026-01-10 | 2026-01-09 | 1 | 2026-02-13 | View Edit Delete | ||||||||||||
| 963256 | 56526 | RINOMICINE POLVO PARA SUSPENSIÓN ORAL | RINOMICINE POLVO PARA SUSPENSIÓN ORAL , 10 sobres | N/A (más de 4 PA) | 35 | 10 | 64 | 10 sobres | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/56526/56526_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/56526/56526_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27143 | 27143 | 1985-11-01 | 1 | 1 | 1 | 1985-11-01 | 1985-11-01 | 1 | 2012-01-02 | View Edit Delete |